Surveillance of serious adverse events following immunization in resource poor settings
2011

Surveillance of Adverse Events After Vaccination in Poor Settings

publication

Author Information

Author(s): Breugelmans Gabrielle J, Gessner Bradford

Primary Institution: Agence de Medecine Preventive, c/o Institut Pasteur, 75724 Paris Cedex 15, France

Hypothesis

Vaccine safety profiles cannot be generalized to developing countries due to local influences.

Conclusion

There is an urgent need for effective surveillance of serious adverse events following immunization in resource-poor settings.

Supporting Evidence

  • Vaccine safety is evaluated through various studies and surveillance.
  • Low-income countries often lack the resources for effective vaccine safety monitoring.
  • The introduction of new vaccines in sub-Saharan Africa increases the need for safety surveillance.

Takeaway

Vaccines are important for health, but we need to make sure they are safe, especially in poorer countries where things can be different.

Methodology

The study discusses the need for functional pharmacovigilance systems and the development of surveillance tools for monitoring vaccine safety.

Limitations

Few low-income economies have functional national pharmacovigilance systems due to lack of resources.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication